HOME > MARKETS > COMPANY NEWS
  COMPANY NEWS
COMPANY
USFDA inspects Indoco Remedies’ manufacturing facilities in Goa
Jul-27-2024

United States Food and Drug Administration (USFDA) has inspected Indoco Remedies’ manufacturing facilities at Plant II (Sterile) and Plant III located at Goa (Facility) from July 16, 2024 to July 26, 2024. On conclusion of the inspection, the company received 7 observations in Form 483. The company is addressing the observations comprehensively and will respond to the USFDA within the stipulated timeframe.

Indoco Remedies is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs) in India.


  RELATED NEWS >>